Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 2 |
2023 | 1 |
2024 | 2 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Epigenetic priming enhances antitumor immunity in platinum-resistant ovarian cancer.
J Clin Invest. 2022 Jul 15;132(14):e158800. doi: 10.1172/JCI158800.
J Clin Invest. 2022.
PMID: 35671108
Free PMC article.
Clinical Trial.
Nanoparticle Targeting in Chemo-Resistant Ovarian Cancer Reveals Dual Axis of Therapeutic Vulnerability Involving Cholesterol Uptake and Cell Redox Balance.
Wang Y, Calvert AE, Cardenas H, Rink JS, Nahotko D, Qiang W, Ndukwe CE, Chen F, Keathley R, Zhang Y, Cheng JX, Thaxton CS, Matei D.
Wang Y, et al. Among authors: keathley r.
Adv Sci (Weinh). 2024 Apr;11(13):e2305212. doi: 10.1002/advs.202305212. Epub 2024 Jan 23.
Adv Sci (Weinh). 2024.
PMID: 38263873
Free PMC article.
Item in Clipboard
Ovarian cancer cell fate regulation by the dynamics between saturated and unsaturated fatty acids.
Zhao G, Tan Y, Cardenas H, Vayngart D, Wang Y, Huang H, Keathley R, Wei JJ, Ferreira CR, Orsulic S, Cheng JX, Matei D.
Zhao G, et al. Among authors: keathley r.
Proc Natl Acad Sci U S A. 2022 Oct 11;119(41):e2203480119. doi: 10.1073/pnas.2203480119. Epub 2022 Oct 5.
Proc Natl Acad Sci U S A. 2022.
PMID: 36197994
Free PMC article.
Item in Clipboard
Preclinical Evaluation of NTX-301, a Novel DNA Hypomethylating Agent in Ovarian Cancer.
Wang Y, Situ X, Cardenas H, Siu E, Alhunayan SA, Keathley R, Tanner E, Wei JJ, Tan Y, Prabhu Dessai CV, Cheng JX, Matei D.
Wang Y, et al. Among authors: keathley r.
Clin Cancer Res. 2024 Mar 15;30(6):1175-1188. doi: 10.1158/1078-0432.CCR-23-2368.
Clin Cancer Res. 2024.
PMID: 38231483
Item in Clipboard
Integrated Multi-Omic Analysis Reveals Immunosuppressive Phenotype Associated with Poor Outcomes in High-Grade Serous Ovarian Cancer.
Keathley R, Kocherginsky M, Davuluri R, Matei D.
Keathley R, et al.
Cancers (Basel). 2023 Jul 17;15(14):3649. doi: 10.3390/cancers15143649.
Cancers (Basel). 2023.
PMID: 37509311
Free PMC article.
Item in Clipboard
Cite
Cite